Bruker [BRKR] vs Stryker [SYK] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bruker Corporation wins in 5 metrics, Stryker Corporation wins in 16 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bruker Corporation Stryker Corporation Better
P/E Ratio (TTM) 74.88 39.21 Stryker Corporation
Price-to-Book Ratio 2.24 5.62 Bruker Corporation
Debt-to-Equity Ratio 81.38 72.97 Stryker Corporation
PEG Ratio 6.74 0.72 Stryker Corporation
EV/EBITDA 14.63 19.90 Bruker Corporation
Profit Margin (TTM) -0.25% 12.92% Stryker Corporation
Operating Margin (TTM) 6.58% 27.24% Stryker Corporation
EBITDA Margin (TTM) 6.58% 27.24% Stryker Corporation
Return on Equity -0.38% 15.08% Stryker Corporation
Return on Assets (TTM) 2.90% 7.92% Stryker Corporation
Free Cash Flow (TTM) $13.90M $4.28B Stryker Corporation
Dividend Yield 0.65% 0.97% Stryker Corporation
1-Year Return 41.59% -17.25% Bruker Corporation
Price-to-Sales Ratio (TTM) 1.60 5.02 Bruker Corporation
Enterprise Value $7.31B $138.30B Stryker Corporation
EV/Revenue Ratio 2.13 5.51 Bruker Corporation
Gross Profit Margin (TTM) 45.97% 64.54% Stryker Corporation
Revenue per Share (TTM) $23 $66 Stryker Corporation
Earnings per Share (Diluted) $-0.15 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.20 0.93 Stryker Corporation
Short % of Float 17.68% 1.20% Stryker Corporation

Bruker Corporation vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bruker Corporation4.43%0.66%32.07%72.86%24.00%17.71%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bruker Corporation41.59%-28.15%-24.98%125.58%203.81%984.60%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Bruker Corporation vs Stryker Corporation

MetricBRKRSYK
Market Information
Market Cap i$5.56B$126.25B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i2,049,2831,881,406
90 Day Avg. Volume i2,108,1082,161,139
Last Close$56.63$307.94
52 Week Range$28.53 - $64.54$281.00 - $404.87
% from 52W High-12.26%-23.94%
All-Time High$94.86 (Mar 18, 2024)$406.19 (Jan 27, 2025)
% from All-Time High-40.30%-24.19%
Growth Metrics
Quarterly Revenue Growth0.00%0.11%
Quarterly Earnings Growth0.90%0.56%
Financial Health
Profit Margin (TTM) i0.00%0.13%
Operating Margin (TTM) i0.07%0.27%
Return on Equity (TTM) i0.00%0.15%
Debt to Equity (MRQ) i81.3872.97
Cash & Liquidity
Book Value per Share (MRQ)$16.15$58.61
Cash per Share (MRQ)$1.96$10.71
Operating Cash Flow (TTM) i$134.10M$5.04B
Levered Free Cash Flow (TTM) i$216.96M$4.17B
Dividends
Last 12-Month Dividend Yield i0.65%0.97%
Last 12-Month Dividend i$0.25$3.40

Valuation & Enterprise Metrics Analysis: Bruker Corporation vs Stryker Corporation

MetricBRKR (Apr 26, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i74.8839.21
Forward P/E i15.0119.67
PEG Ratio i6.740.72
Price to Sales (TTM) i1.605.02
Price to Book (MRQ) i2.245.62
Market Capitalization
Market Capitalization i$5.56B$126.25B
Enterprise Value i$7.31B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i2.135.51
Enterprise to EBITDA i14.6319.90
Risk & Other Metrics
Beta i1.200.93
Book Value per Share (MRQ) i$16.15$58.61

Financial Statements Comparison: Bruker Corporation vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBRKR (2025)SYK (2025)
Revenue/Sales i3.44B25.12B
Cost of Goods Sold i1.86B9.05B
COGS % of Revenue i54.1%36.0%
Gross Profit i1.58B16.07B
Gross Margin i45.9%64.0%
Research & Development i395.20M1.62B
Operating Income (EBIT) i236.00M5.06B
Operating Margin i6.9%20.1%
EBITDA i456.80M6.48B
EBITDA Margin i13.3%25.8%
Pre-Tax Income i22.00M4.51B
Pre-Tax Income % of Revenue i0.6%18.0%
Income Tax i29.30M1.27B
Income Tax % of Revenue i0.9%5.0%
Net Income (Profit) i-8.30M3.25B
Profit Margin i-0.2%12.9%

Balance Sheet & Liquidity Metrics

MetricBRKR (2025)SYK (2025)
Cash & Equivalents i298.80M4.01B
Total Current Assets i2.21B14.76B
Total Current Assets % of Revenue i64.4%58.7%
Total Current Liabilities i1.28B7.79B
Total Current Liabilities % of Revenue i37.2%31.0%
Long-Term Debt i1.99B14.86B
Long-Term Debt % of Revenue i57.9%59.2%
Total Shareholders Equity i2.51B22.42B
Retained Earnings i2.36B20.47B
Retained Earnings % of Revenue i68.7%81.5%
Property, Plant & Equipment i165.80M1.79B

Cash Flow Statement Comparison

MetricBRKR (2025)SYK (2025)
Operating Cash Flow i82.50M4.70B
Operating Cash Flow % of Revenue i2.4%18.7%
Capital Expenditures i-90.80M-761.00M
Free Cash Flow i13.90M4.28B
FCF Margin i0.4%17.1%
Debt Repayment i-1.25B-1.40B
Common Stock Repurchase i-10.00MN/A

Short Interest & Institutional Ownership Analysis

MetricBRKRSYK
Shares Short i12.53M4.42M
Short Ratio i6.301.95
Short % of Float i17.68%1.20%
Shares Outstanding i152.14M382.50M
Float Shares i103.57M346.55M
% Held by Insiders i26.95%5.37%
% Held by Institutions i91.32%82.09%
% Held by Public i-18.27%12.54%

Dividend Analysis & Yield Comparison: Bruker Corporation vs Stryker Corporation

MetricBRKRSYK
Last 12-Month Dividend i$0.25$3.40
Last 12-Month Dividend Yield i0.65%0.97%
3-Year Avg Annual Dividend i$0.20$3.23
3-Year Avg Dividend Yield i0.10%0.24%
3-Year Total Dividends i$0.60$9.69
Ex-Dividend DateMar 23, 2026Dec 31, 2025